News
BCCD News
Business News & Information
British Airways: Heathrow T5 World's best. Introducing services to Seoul in South Korea
British Airways are closing the rute between Copenhagen Airport and London City Airport
Miller Rosenfalck announce a change to their management structure
British Airways offers fast track service at Copenhagen Airport
2010 Culture Prize awarded to Ian Burns of That Theatre
Abuse of the employer’s trade secrets
New Danish Supreme Court ruling on buy-back provisions in incentive programme
Finance for Foreigners
Refurbishment of the Copenhagen Marriott Hotel
Employees in Denmark - need to know labour law
Promotion of Pharmaceutical Products and the Bribery Act 2010
Fleet Flagship visits Copenhagen
Trying out the Triathlon
Data Protection - an international issue
Patent Box
Better Place and Renault launch
IT Branchen's Annual Conference
State of the World 2011 Launch
Jutlandia Memorial Event
Burns-Supper
Working together on intellectual property and life sciences
UK Nordic Baltic Summit
UK Offshore Wind Supply Chain Seminar 2010
10 Years of Rethinking
J K Rowling receives award
Crowne Plaza
The President of Ireland Official Visit
World Translation hailed as a Gazelle
The New Pioneers
World Climate Solutions Conference
New Copenhagen to London City route
UK's Emergency Budget
Network connects UK and Ireland businesses to europe
ISS - New CEO
Marriott opens Midtown Grill
Mongolia 2010 Expedition - Press Release
New appointments and a new look signal rapid growth for European business law firm Miller Rosenfalck
BCCD Annual Supplements
E-mails to members
Invites and reminders
Newsletter
Newsletter Sign-up
Newsletter Archive
News archive

 
10 Years of RethinkingPrint

Ten years have passed since Novozymes emerged as an independent company following many years as a division of the healthcare company Novo Nordisk. At the start Novozymes had around 3,200 employees and a net revenue of DKK 5 billion. Today the company employs 5,200 people globally and its revenue for the first nine months of 2010 was DKK 7.3 billion.

Driven by innovation

This growth is created through a huge dedication to innovation and by running an efficient, well-diversified business. 14% of revenue is spent on R&D, and over the years Novozymes has come up with a large number of game-changing new products in a wide number of industries.

One of these products is Novozymes Cellic® CTec2, which enables the production of cellulosic ethanol made from waste materials such as straw and corn stover. A number of Novozymes’ products allow customers to replace petrochemicals with biomaterials, for example allowing producers of detergents to replace surfactants with enzymatic solutions.

In the same period Novozymes has taken its technology to new industries. Its BioBusiness division produces and sells microorganisms and pharmaceutical ingredients, and it is expected to grow significantly in the future.

The world is changing, and Novozymes with it

Since it began Novozymes has talked about sustainability. But today sustainable solutions are becoming more attractive to businesses because of the pressure on resources. And that is new. “The world’s increasing need for sustainable solutions, coupled with our ability to deliver innovative solutions based on biotechnology, is allowing us to fulfill our ambition to change the world together with our customers,” says CEO Steen Riisgaard. “I am certain these trends will only strengthen in the future. As the saying goes, somebody’s got to decide the future, and it might as well be us.”

The anniversary was celebrated globally at all Novozymes’ sites, including those in Australia, China, Switzerland, California, and many more.

Maraino A Davies attended the event in Denmark and congratulated Steen Riisgaard.

 
Copyright © 2012 British Chamber of Commerce in Denmark, BCCD and British Import Union, BIU   Arrow grey bottommenu  Credits   Arrow grey bottommenu  Privacy Policy   Arrow grey bottommenu  Legal Notice   Arrow grey bottommenu  Sitemap
The latest update of this web site was funded by Chevron Denmark and developed by Nemetos 
The website is licensed by Sitecore CMS and hosted by Nemetos with  Ankiro search engine technology